Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma
Clinical trial NCT00062036 · COMPLETED
Trial details
- NCT number
- NCT00062036
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2007-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.